Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METARAMINOL Cause Condition aggravated? 40 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Condition aggravated have been filed in association with METARAMINOL. This represents 24.2% of all adverse event reports for METARAMINOL.

40
Reports of Condition aggravated with METARAMINOL
24.2%
of all METARAMINOL reports
21
Deaths
6
Hospitalizations

How Dangerous Is Condition aggravated From METARAMINOL?

Of the 40 reports, 21 (52.5%) resulted in death, 6 (15.0%) required hospitalization, and 3 (7.5%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METARAMINOL. However, 40 reports have been filed with the FAERS database.

What Other Side Effects Does METARAMINOL Cause?

Respiratory failure (37) Drug ineffective (23) Hypotension (19) Anaphylactic reaction (15) Maternal exposure during pregnancy (12) Confusion postoperative (11) Foetal exposure during pregnancy (11) Mental status changes postoperative (11) Metabolic alkalosis (11) Rash (11)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which METARAMINOL Alternatives Have Lower Condition aggravated Risk?

METARAMINOL vs METAXALONE METARAMINOL vs METFORMIN METARAMINOL vs METFORMIN\PIOGLITAZONE METARAMINOL vs METFORMIN\ROSIGLITAZONE METARAMINOL vs METFORMIN\SAXAGLIPTIN

Related Pages

METARAMINOL Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated METARAMINOL Demographics